Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (61-70 of 681) with videos related to

Pageof 69
Sort By:
Molecular Carcinogenesis|July 1, 1997
Dideoxy fingerprinting assay for BRCA1 mutation analysisJ M Lancaster, A Berchuck, P A Futreal, et al.
The British Journal of Ophthalmology|August 31, 2020
Impact of anxiety and depression on progression to glaucoma among glaucoma suspectsSamuel Berchuck, Alessandro Jammal, Sayan Mukherjee, et al.
Cancer Research|November 14, 1997
PTEN/MMAC1 mutations in endometrial cancersJ I Risinger, A K Hayes, A Berchuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?Andrew Berchuck, Angeles Alvarez Secord, Haley A Moss, et al.
The American Journal of Surgical Pathology|May 9, 2000
Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovaryW F Moore, R C Bentley, A Berchuck, et al.
Cancer|January 12, 2000
Managing hereditary ovarian cancer riskA Berchuck, J M Schildkraut, J R Marks, et al.
Gynecologic Oncology|December 2, 2017
Urinary diversion in the genitourinary cancer survivorOmari K Johnson, Andrew Berchuck, Angeles A Secord, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancersJohn I Risinger, G Larry Maxwell, Andrew Berchuck, et al.
Cancer|May 1, 1991
Stage I small cell carcinoma of the vulva treated with vulvectomy, lymphadenectomy, and adjuvant chemotherapyW Cliby, A P Soisson, A Berchuck, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
Pageof 69

Showing results (61-70 of 681) with videos related to

Sort By:
Pageof 69
Molecular Carcinogenesis|July 1, 1997
Dideoxy fingerprinting assay for BRCA1 mutation analysisJ M Lancaster, A Berchuck, P A Futreal, et al.
The British Journal of Ophthalmology|August 31, 2020
Impact of anxiety and depression on progression to glaucoma among glaucoma suspectsSamuel Berchuck, Alessandro Jammal, Sayan Mukherjee, et al.
Cancer Research|November 14, 1997
PTEN/MMAC1 mutations in endometrial cancersJ I Risinger, A K Hayes, A Berchuck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?Andrew Berchuck, Angeles Alvarez Secord, Haley A Moss, et al.
The American Journal of Surgical Pathology|May 9, 2000
Some mullerian inclusion cysts in lymph nodes may sometimes be metastases from serous borderline tumors of the ovaryW F Moore, R C Bentley, A Berchuck, et al.
Cancer|January 12, 2000
Managing hereditary ovarian cancer riskA Berchuck, J M Schildkraut, J R Marks, et al.
Gynecologic Oncology|December 2, 2017
Urinary diversion in the genitourinary cancer survivorOmari K Johnson, Andrew Berchuck, Angeles A Secord, et al.
Annals of the New York Academy of Sciences|May 2, 2003
Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancersJohn I Risinger, G Larry Maxwell, Andrew Berchuck, et al.
Cancer|May 1, 1991
Stage I small cell carcinoma of the vulva treated with vulvectomy, lymphadenectomy, and adjuvant chemotherapyW Cliby, A P Soisson, A Berchuck, et al.
Plos Genetics|June 30, 2018
The importance of using public data to validate reported associationsGeorgia Chenevix-Trench, Jonathan Beesley, Paul D P Pharoah, et al.
Pageof 69